it is naturally occurring, nontoxic, and is active at a very low nanomolar concentration.11 Another piece of research described GHK-Cu as a safe, inexpensive, extensively studied compound.3 These conclusions primarily apply to topical GHK-Cu, but even with injectables, the lack of serious adverse events in animal subjects points to a general tolerability regardless of the route of administration
Its particularly valuable for individuals with severely compromised metabolism, chronic fatigue, and low energy who havent responded to traditional approaches
The best outcome from July's meeting is not simply "yes" or "no" on compounding eligibility it is a regulatory posture that treats these compounds with the scientific rigor their biological plausibility warrants
the mouse study used dosing three times daily
Combined, they give your body what it needs to actually finish healing instead of hovering at 80% indefinitely